Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 2551-2600 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT07170423
Automated Text Message Reminders to Promote Hearing Aid Adoption
NA
Not yet recruiting
190 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2027
1 condition
1 sponsor
1 location
NCT07171138
This Study Will Use Real-time Pressure Mapping Technology to Determine Which Positioning Strategies and Devices Exert the Least Amount of Pressure on Peri-operative Burn Patients
NA
Not yet recruiting
80 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2027
1 condition
1 sponsor
0 locations
NCT07171346
Post Operative Use of Neuromuscular Electrical Stimulation (NMES) Device for ACLR Patients
NA
Not yet recruiting
25 participants
Started: Nov 30, 2025 · Completed: Jun 30, 2028
5 conditions
1 sponsor
1 location
NCT07200531
Does Psychotherapy Change the Gut Microbiome in Women of Child-bearing Age?
NA
Not yet recruiting
30 participants
Started: Nov 30, 2025 · Completed: Jul 31, 2026
1 condition
1 sponsor
0 locations
NCT07154823
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
N/A
Not yet recruiting
50 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2035
1 condition
1 sponsor
0 locations
NCT07193771
Altitude and Outcomes in Pediatric ARDS: A Multicenter Study
N/A
Not yet recruiting
1,600 participants
Started: Nov 30, 2025 · Completed: Mar 31, 2028
3 conditions
3 sponsors
0 locations
NCT07201311
Combined Gastrointestinal Decontamination in Acute Severe Poisoning
PHASE2
Not yet recruiting
200 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2027
2 conditions
1 sponsor
1 location
NCT06660862
Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
PHASE4
Not yet recruiting
80 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2029
1 condition
1 sponsor
1 location
NCT07046936
Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer
N/A
Recruiting
30 participants
Started: Nov 30, 2025 · Completed: Apr 30, 2027
1 condition
1 sponsor
2 locations
NCT06769165
EMDR Treatment of Conditioned Nausea and Vomiting in Cancer Survivors
NA
Recruiting
20 participants
Started: Nov 30, 2025 · Completed: Aug 1, 2026
1 condition
1 sponsor
1 location
NCT06930625
A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs
PHASE3
Recruiting
119 participants
Started: Nov 30, 2025 · Completed: Mar 31, 2029
1 condition
1 sponsor
32 locations
NCT07096297
Luspatercept + Darbepoetin in MDS
PHASE2
Not yet recruiting
54 participants
Started: Nov 30, 2025 · Completed: May 31, 2030
1 condition
2 sponsors
1 location
NCT07087340
Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop - Genesis
NA
Not yet recruiting
6 participants
Started: Nov 30, 2025 · Completed: Mar 31, 2026
1 condition
4 sponsors
1 location
NCT07201974
Virtual Reality for Post-Stroke Gait Rehabilitation
NA
Not yet recruiting
40 participants
Started: Nov 30, 2025 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT07201376
Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically
N/A
Not yet recruiting
125 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2027
2 conditions
2 sponsors
0 locations
NCT07201818
LET for Fibromyalgia
NA
Not yet recruiting
40 participants
Started: Nov 30, 2025 · Completed: Jan 31, 2027
1 condition
2 sponsors
1 location
NCT07201402
Long Term Evaluation of Scapular-inserted Contraceptive Implants
PHASE2
Not yet recruiting
62 participants
Started: Nov 30, 2025 · Completed: Oct 31, 2027
1 condition
2 sponsors
2 locations
NCT07200609
The Effects of Virtual Reality-Based Gamified Rehabilitation in Children With Hemophilia
NA
Not yet recruiting
20 participants
Started: Nov 30, 2025 · Completed: Sep 30, 2026
1 condition
1 sponsor
0 locations
NCT07142512
Helping Couples Communicate Better: Does This Help Persons With Type 2 Diabetes Respond Better to a Step Count Prescription?
PHASE2/PHASE3
Not yet recruiting
200 participants
Started: Nov 30, 2025 · Completed: Dec 31, 2027
1 condition
2 sponsors
3 locations
NCT06980480
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
PHASE3
Not yet recruiting
183 participants
Started: Nov 29, 2025 · Completed: Sep 11, 2028
2 conditions
3 sponsors
17 locations
NCT06694181
Safe and Explainable AI
N/A
Not yet recruiting
300,000 participants
Started: Nov 29, 2025 · Completed: Nov 30, 2028
4 conditions
1 sponsor
0 locations
NCT07040319
Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV
PHASE1/PHASE2
Not yet recruiting
30 participants
Started: Nov 28, 2025 · Completed: Jul 30, 2027
1 condition
4 sponsors
10 locations
NCT03644641
The Influence of Prone Position for Spinal Surgery on Visual Acuity
NA
Not yet recruiting
60 participants
Started: Nov 28, 2025 · Completed: Dec 30, 2029
1 condition
1 sponsor
1 location
NCT07217587
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
PHASE3
Not yet recruiting
115 participants
Started: Nov 28, 2025 · Completed: Sep 4, 2028
1 condition
1 sponsor
0 locations
NCT07207070
A Randomised, Open-label, Multicentre Phase III Clinical Study to Evaluate the Efficacy and Safety of JS105 Combined With Dalpiciclib and Fulvestrant Compared With Dalpiciclib and Fulvestrant in Patients With PIK3CA-mutated, HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer.
PHASE3
Not yet recruiting
312 participants
Started: Nov 28, 2025 · Completed: May 31, 2030
1 condition
1 sponsor
2 locations
NCT07218809
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
PHASE3
Not yet recruiting
1,100 participants
Started: Nov 28, 2025 · Completed: May 27, 2030
1 condition
4 sponsors
0 locations
NCT07000110
Anifrolumab Malignancy and Serious Infections Study
N/A
Not yet recruiting
3,506 participants
Started: Nov 28, 2025 · Completed: Nov 30, 2031
1 condition
2 sponsors
0 locations
NCT07191561
Hepatic Lipid Metabolism-Alcohol Use Disorder
N/A
Not yet recruiting
25 participants
Started: Nov 28, 2025 · Completed: Nov 30, 2029
1 condition
1 sponsor
1 location
NCT07202546
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
PHASE2
Not yet recruiting
550 participants
Started: Nov 28, 2025 · Completed: Mar 19, 2029
1 condition
1 sponsor
0 locations
NCT06451757
KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
PHASE3
Not yet recruiting
150 participants
Started: Nov 28, 2025 · Completed: Jan 2, 2028
4 conditions
1 sponsor
0 locations
NCT07206056
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
PHASE1/PHASE2
Recruiting
188 participants
Started: Nov 28, 2025 · Completed: Dec 17, 2030
1 condition
1 sponsor
2 locations
NCT04962737
Non-invasive Neuromodulation NESA Through Somatosensory Evoked Potentials and Sympathetic-cutaneous Responses
NA
Not yet recruiting
15 participants
Started: Nov 28, 2025 · Completed: Oct 20, 2026
1 condition
1 sponsor
0 locations
NCT07194070
A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry
N/A
Recruiting
175 participants
Started: Nov 28, 2025 · Completed: Sep 30, 2030
1 condition
1 sponsor
3 locations
NCT06886009
Spesolimab Post-marketing Surveillance in Korean Patients With Flares With Generalized Pustular Psoriasis
N/A
Not yet recruiting
21 participants
Started: Nov 28, 2025 · Completed: Jun 8, 2029
1 condition
1 sponsor
4 locations
NCT06760208
A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market
N/A
Not yet recruiting
660 participants
Started: Nov 28, 2025 · Completed: Oct 30, 2028
2 conditions
1 sponsor
1 location
NCT05558709
Social-cognitive Functioning: Validation of a New Neuropsychological Test
NA
Recruiting
120 participants
Started: Nov 28, 2025 · Completed: Nov 28, 2029
3 conditions
1 sponsor
1 location
NCT07201558
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
PHASE1
Not yet recruiting
48 participants
Started: Nov 28, 2025 · Completed: Jun 27, 2028
2 conditions
1 sponsor
0 locations
NCT07142239
Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid Syndrome
N/A
Not yet recruiting
150 participants
Started: Nov 27, 2025 · Completed: Jun 30, 2027
1 condition
1 sponsor
0 locations
NCT07133997
Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia
PHASE1
Not yet recruiting
26 participants
Started: Nov 26, 2025 · Completed: May 8, 2027
2 conditions
2 sponsors
1 location
NCT06728098
Safety and Tolerability Evaluation of Akkermansia Muciniphila
NA
Recruiting
108 participants
Started: Nov 25, 2025 · Completed: Mar 25, 2026
1 condition
1 sponsor
1 location
NCT07196644
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
PHASE2
Not yet recruiting
125 participants
Started: Nov 25, 2025 · Completed: Dec 31, 2030
1 condition
1 sponsor
0 locations
NCT07055282
SGLT2i in Kidney Stones
EARLY_PHASE1
Not yet recruiting
32 participants
Started: Nov 25, 2025 · Completed: Dec 31, 2027
1 condition
3 sponsors
1 location
NCT07165054
Periodontal Pathogens and Atherom Plaque The Number of Mitochondrial DNA Copies
N/A
Recruiting
55 participants
Started: Nov 25, 2025 · Completed: Dec 1, 2026
4 conditions
1 sponsor
1 location
NCT07010276
Deep Brain Stimulation vs. Vagus Nerve Stimulation for Epileptic Spasms
NA
Not yet recruiting
20 participants
Started: Nov 24, 2025 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT07209111
A Clinical Study of MK-1084 in People With Advanced Solid Tumors (MK-1084-014)
PHASE2
Not yet recruiting
150 participants
Started: Nov 24, 2025 · Completed: Apr 9, 2032
1 condition
1 sponsor
0 locations
NCT06705764
Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)
PHASE4
Not yet recruiting
100 participants
Started: Nov 24, 2025 · Completed: Nov 30, 2026
1 condition
2 sponsors
2 locations
NCT07216066
First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
PHASE1
Not yet recruiting
46 participants
Started: Nov 24, 2025 · Completed: May 28, 2029
1 condition
1 sponsor
0 locations
NCT07134088
A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia
PHASE1/PHASE2
Not yet recruiting
104 participants
Started: Nov 21, 2025 · Completed: Jun 18, 2030
2 conditions
1 sponsor
0 locations
NCT06921707
Pilot Trial for WounDx™ Clinical Decision Support Tool
NA
Not yet recruiting
40 participants
Started: Nov 21, 2025 · Completed: Jun 20, 2026
7 conditions
8 sponsors
5 locations
NCT06681818
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
NA
Recruiting
125 participants
Started: Nov 21, 2025 · Completed: Jan 1, 2039
2 conditions
1 sponsor
1 location
Previous
1
More pages
49
50
51
52
53
54
55
More pages
2369
Next